文献速递功能神经外科

癫痫手术中有创监测策略的成本效益分析

Cost-effectiveness of invasive monitoring strategies in epilepsy surgery.
PubMed 文献 · J Neurosurg · 2022-12-30

该经济学评价研究采用决策分析模型,基于系统综述和荟萃分析数据模拟硬膜下电极(SDE)与立体脑电图(sEEG)两种有创监测策略的风险与获益。sEEG较SDE成本增加274美元,有效概率增加0.02,增量成本效果比(ICER)为每获得一例阳性结局12,630美元;敏感性分析显示模型结果一致,策略成本是对模型结果影响最大的参数。作者结论为两种策略在成本效益上几乎等效。

要点

  • sEEG较SDE成本增加274美元,有效概率增加0.02,ICER为每阳性结局12,630美元。
  • 敏感性分析在文献报道的临床参数范围内结果一致,策略成本为最 influential 参数。
  • 基于现有观察数据与并发症成本估计,SDE与sEEG的成本效益几乎等效。

核心结论

  • 基于现有观察数据与并发症成本估计,有创监测采用SDE或sEEG在成本效益上几乎等效。

研究设计与样本

  • 该研究为经济学评价研究,采用决策分析模型模拟SDE与sEEG有创监测策略的风险与获益。
  • 模型数据来自已发表的系统综述和荟萃分析中的国际代表性样本,成本值来自近期发表的一项单中心成本效用分析。
  • 模型对耐药性癫痫的典型患者进行基础案例分析,临床参数取自文献中有创监测的系统综述。

主要发现

  • sEEG有创监测较SDE成本增加274美元,有效概率增加0.02,ICER为每获得一例阳性结局12,630美元。
  • 敏感性分析广泛变化参数,在文献报道的临床参数范围内模型结果一致。
  • 单因素敏感性分析显示,有创监测策略的成本是对模型结果影响最大的参数。

关键数值与推荐

  • 主要结局指标为有创监测后阳性结局的概率,定义为无并发症的癫痫发作改善。
  • 成本效益以增量成本效果比(ICER)衡量。
  • sEEG较SDE成本增加274美元,有效概率增加0.02,ICER为12,630美元每阳性结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Drug-resistant epilepsy occurs in up to 40% of patients with epilepsy who may be considered for epilepsy surgery. For drug-resistant focal epilepsy, up to 50% of patients require invasive monitoring prior to surgery. Of the most common invasive monitoring strategies (subdural electrodes [SDEs] and stereo-electroencephalography [sEEG]), the most cost-effective strategy is unknown despite substantial differences in morbidity profiles. METHODS: Using data collected from an internationally representative sample published in available systematic reviews and meta-analyses, this economic evaluation study employs a decision analysis model to simulate the risks and benefits of SDE and sEEG invasive monitoring strategies. In this model, patients faced differing risks of morbidity, mortality, resection, and seizure freedom depending on which invasive monitoring strategy they underwent. A range of cost values was obtained from a recently published single-center cost-utility analysis. The model considers a base case simulation of a characteristic patient with drug-resistant epilepsy using clinical parameters obtained from systematic reviews of invasive monitoring available in the literature. The main outcome measure was the probability of a positive outcome after invasive monitoring, which was defined as improvement in seizures without a complication. Cost-effectiveness was measured using an incremental cost-effectiveness ratio (ICER). RESULTS: Invasive monitoring with sEEG had an increased cost of $274 and increased probability of effectiveness of 0.02 compared with SDEs, yielding an ICER of $12,630 per positive outcome obtained. Sensitivity analyses varied parameters widely and revealed consistent model results across the range of clinical parameters reported in the literature. One-way sensitivity analyses revealed that invasive monitoring strategy costs were the most influential parameter for model outcome. CONCLUSIONS: In this analysis, based on available observational data and estimates of complication costs, invasive monitoring with either SDEs or sEEG was nearly equivalent in terms of cost-effectiveness.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Abel TJ, Muthiah N, Hect JL, et al. Cost-effectiveness of invasive monitoring strategies in epilepsy surgery. J Neurosurg. 2022. PMID: 36585866. doi:10.3171/2022.11.JNS221744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。